• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌临床分离株中乙胺丁醇和异烟肼同时耐药

Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.

作者信息

Gupta Pushpa, Jadaun G P S, Das Ram, Gupta U D, Srivastava Kiran, Chauhan Aradhana, Sharma V D, Chauhan D S, Katoch V M

机构信息

Department of Microbiology & Molecular Biology, National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Agra, India.

出版信息

Indian J Med Res. 2006 Feb;123(2):125-30.

PMID:16575110
Abstract

BACKGROUND & OBJECTIVE: There is a need to understand the nature of drug resistance patterns and predictors of emergence of drug resistance in Mycobacterium tuberculosis. There could be common factors/mechanisms for resistance to the drugs, isoniazid and ethambutol, both acting on cell wall. The present study was conducted to analyze the antimycobacterial susceptibility patterns of M. tuberculosis isolates to determine the minimum inhibitory concentrations (MICs) of ethambutol for M. tuberculosis; and to find out possible association of ethambutol resistance with isoniazid resistance.

METHODS

A total of 380 M. tuberculosis isolates were tested for their susceptibilities to ethambutol at 2, 4, 6 microg/ml, isoniazid at 1 microg/ml and rifampicin at 64 microg/ml using MIC method.

RESULTS

44.21, 24.73 and 14.21 per cent isolates were resistant to ethambutol at concentrations of 2, 4 and 6 microg/ml respectively. At 6 microg/ml of ethambutol concentration, 85.18 per cent ethambutol resistant isolates were resistant to isoniazid also. At the same ethambutol concentration a fraction of 28.75 per cent isoniazid resistant isolates were ethambutol resistant.

INTERPRETATION & CONCLUSION: Ethambutol resistance was accompanied with isoniazid resistance in a large percentage of isolates whereas ethambutol resistance was weakly linked with multidrug resistance. On the other hand, association between isoniazid and ethambutol resistance was weak showing one way linkage.

摘要

背景与目的

有必要了解结核分枝杆菌耐药模式的本质以及耐药性出现的预测因素。对于作用于细胞壁的异烟肼和乙胺丁醇这两种药物,可能存在共同的耐药因素/机制。本研究旨在分析结核分枝杆菌分离株的抗分枝杆菌药敏模式,以确定乙胺丁醇对结核分枝杆菌的最低抑菌浓度(MIC);并找出乙胺丁醇耐药与异烟肼耐药之间可能存在的关联。

方法

采用MIC法对总共380株结核分枝杆菌分离株进行药敏试验,检测其对2、4、6微克/毫升乙胺丁醇、1微克/毫升异烟肼和64微克/毫升利福平的敏感性。

结果

分别有44.21%、24.73%和14.21%的分离株对2、4和6微克/毫升浓度的乙胺丁醇耐药。在乙胺丁醇浓度为6微克/毫升时,85.18%的乙胺丁醇耐药分离株也对异烟肼耐药。在相同的乙胺丁醇浓度下,28.75%的异烟肼耐药分离株对乙胺丁醇耐药。

解读与结论

在很大比例的分离株中,乙胺丁醇耐药与异烟肼耐药同时存在,而乙胺丁醇耐药与多药耐药的关联较弱。另一方面,异烟肼与乙胺丁醇耐药之间的关联较弱,呈单向联系。

相似文献

1
Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.结核分枝杆菌临床分离株中乙胺丁醇和异烟肼同时耐药
Indian J Med Res. 2006 Feb;123(2):125-30.
2
Novel mutations in emb B gene of ethambutol resistant isolates of Mycobacterium tuberculosis: a preliminary report.结核分枝杆菌乙胺丁醇耐药菌株emb B基因的新突变:初步报告
Indian J Med Res. 2008 Nov;128(5):634-9.
3
[Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].利奈唑胺联合异烟肼和利福平对耐多药结核分枝杆菌临床分离株的作用
Mikrobiyol Bul. 2009 Apr;43(2):293-7.
4
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.评估野生型最低抑菌浓度分布作为确定结核分枝杆菌临床断点的工具。
J Antimicrob Chemother. 2009 Oct;64(4):786-93. doi: 10.1093/jac/dkp262. Epub 2009 Jul 23.
5
Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.耐多药结核分枝杆菌临床分离株相关突变的检测
FEMS Immunol Med Microbiol. 2011 Aug;62(3):321-7. doi: 10.1111/j.1574-695X.2011.00814.x. Epub 2011 Jun 9.
6
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.对异烟肼和乙胺丁醇均耐药的结核分枝杆菌分离株的表型和分子特征
Antimicrob Agents Chemother. 2005 Jun;49(6):2218-25. doi: 10.1128/AAC.49.6.2218-2225.2005.
7
Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.两种抗结核药物组合对结核分枝杆菌的协同作用。
Tuberculosis (Edinb). 2012 May;92(3):260-3. doi: 10.1016/j.tube.2012.01.005. Epub 2012 Feb 16.
8
Mycobacterium resistance to antimycobacterial reagent.分枝杆菌对抗分枝杆菌试剂的耐药性。
Therapie. 1999 Sep-Oct;54(5):623-5.
9
Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.科威特易感性和耐药性临床结核分枝杆菌分离株中embB基因306密码子突变的频率
Tuberculosis (Edinb). 2007 Mar;87(2):123-9. doi: 10.1016/j.tube.2006.05.004. Epub 2007 Feb 7.
10
[Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].[从临床标本中分离出的结核分枝杆菌复合群菌株的耐药率]
Mikrobiyol Bul. 2011 Jan;45(1):36-42.

引用本文的文献

1
Mutations in 406 Are Associated with Low-Level Ethambutol Resistance in Canadian Isolates.406位点的突变与加拿大分离株中的低水平乙胺丁醇耐药性相关。
Antibiotics (Basel). 2024 Jul 4;13(7):624. doi: 10.3390/antibiotics13070624.
2
An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.一个预言:抗结核药物代谢动力学-药效学、临床相关性和临床试验模拟预测未来。
Antimicrob Agents Chemother. 2011 Jan;55(1):24-34. doi: 10.1128/AAC.00749-10. Epub 2010 Oct 11.
3
Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.
结核分枝杆菌外排泵介导的乙胺丁醇单药耐药及乙胺丁醇的药代动力学和药效学。
J Infect Dis. 2010 Apr 15;201(8):1225-31. doi: 10.1086/651377.